RS
RLAY icon

R Squared’s Relay Therapeutics RLAY Stock Holding History

R Squared’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,180
Closed -$4.86K – 1232
2024
Q4 		$4.86K Buy
+1,180
New +$6.42K ﹤0.01% 1317

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

R Squared's RLAY Position: Q1 2025 in Review

R Squared sold out of Relay Therapeutics (RLAY) in Q1 2025, closing a stake of 1,180 shares — an estimated $4.86K sold.

R Squared first reported a position in RLAY in Q4 2024 and held it in 1 quarter. The position peaked at $4.86K in Q4 2024. 207 funds tracked by Wall St. Rank hold RLAY as of Q1 2025.

  • R Squared reported no remaining Relay Therapeutics position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 1,180 Relay Therapeutics shares in Q1 2025, an estimated $4.86K.
  • R Squared first reported a position in Relay Therapeutics in Q4 2024 and held it in 1 quarter.
  • R Squared's Relay Therapeutics position peaked at $4.86K in Q4 2024.
  • 207 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.